Genes reveal risk of recurrence of kidney cancer
Looking at a person's DNA using a technique called DNA [...]
FDA approves adjuvant pembrolizumab for intermediate-high risk kidney cancer
The Food and Drug administration (FDA) in the USA has [...]
Risks and benefits of adjuvant therapy for kidney cancer
Treatment of people with intermediate to high risk renal cell [...]
Positive margins after partial nephrectomy and risk of recurrence in kidney cancer
In this meta-analysis, the results from 101,153 patients with renal [...]
Immune cell helps prevent kidney cancer recurrence
Recurrence occurs when cancer comes back after surgery, or after [...]
Local and regional recurrences of localised kidney cancer after nephrectomy
In this study 15 years of data from a single [...]
Potential biomarker to predict risk of recurrence after nephrectomy for locally advanced kidney cancer
Currently, the search for a reliable biomarker to identify those [...]
Predictive factors for recurrence after complete metastasectomy in metastatic kidney cancer patients
In this retrospective study, published in Science Direct this month, [...]
Long-term risk of recurrence after surgery for kidney cancer
A recent study published in the journal European Urology investigated [...]
Incidence and pattern of recurrence of kidney cancer after robotic partial nephrectomy
A recent study has shown the incidence and pattern of [...]
